To investigate the effects of peritoneal fluid from patients with endometriosis on mouse peritoneal macrophages (MP), peritoneal fluid from endometriosis patients (n = 15) were added to a monolayer of C3H/HeJ mouse peritoneal MP. Tumor necrosis factor-producing activity was measured by the L929 assay activated with FK-23 (a preparation of heat-killed Enterococcus faecalis). Tumor necrosis factor-producing activity of C3H/HeJ mouse peritoneal MP incubated with peritoneal fluid was suppressed in 14 endometriosis patients. Interestingly, in nine endometriosis patients, tumor necrosis factorproducing activity was much lower than seen with mouse peritoneal MP incubated with corticosterone. Peritoneal fluid contains suppressive properties for the activation of peritoneal MP, which might allow the implantation of free endometrial cells or the metaplastic phenomena stimulated by retrograde menstruation. z 1998 Federation of European Microbiological Societies. Published by Elsevier Science B.V.
Introduction
Endometriosis is widely known to be associated with infertility and pelvic pain. But the pathophysiology of endometriosis is poorly understood. In recent hypotheses the etiology and process of this disease have been ascribed to abnormalities of the immune system as follows.
Oosterlynck et al. reported that natural killer (NK)-mediated cytotoxicity was signi¢cantly decreased in women with endometriosis [1] .
Gleicher et al. demonstrated that more than two thirds of endometriosis patients exhibited evidence of abnormal polyclonal B cell activation, which resulted in signi¢cant autoantibody abnormalities [2] .
Not only lymphoid cells but also monocytes or macrophages (MP) have been thought to play a major role in maintaining homeostasis within the peritoneal cavity with endometriosis, in which the existence of local in£ammation, as seen by the increase in peritoneal £uid, adhesion formation and hemorrhagic changes, were found [3, 4] .
The total number of peritoneal macrophages was signi¢cantly increased in these patients [5] . More recently, Braun et al. showed that the cytotoxic func-tion of peritoneal MP in patients with endometriosis was inversely correlated with the severity of the disease [6] .
Therefore, it is very important to investigate the regulatory mechanisms of peritoneal macrophages in order to understand the pathogenesis of endometriosis.
The objective of this study was to evaluate the e¡ects of peritoneal £uid (PF) from patients with endometriosis as a biological modi¢er of MP functions. Included in the variety of macrophage functions are production of an in£ammatory cytokine, tumor necrosis factor (TNF), recognized as one of the most important steps in the sequential biologic reaction in vivo [7] . We focused on the inhibitory e¡ects of PF on TNF production by murine macrophages which are a well-established experimental system as a model of macrophage activation [8] .
Materials and methods

Patient characteristics
PF was obtained from 15 women during laparoscopy in the follicular phase by the Department of Obstetrics and Gynecology, Teikyo University School of Medicine. These preparations were obtained with prior consent from all patients undergoing laparoscopic examination. The mean age of the patients was 29 years (range 23^42). Endometriosis was staged according to the revised American Fertility Society Classi¢cation (Re-AFS) [9] , which revealed six patients with stage I, two with stage II, ¢ve with stage III and two with stage IV.
As a control, PF was obtained from a woman who was suspected to have endometriosis from her clinical history showing severe dysmenorrhea and unexplained infertility. However, she had no endometriosis lesions.
Preparation of PF
PF was aspirated under laparoscopic examination from the cul-de-sac before surgical treatment. After recording the PF's volume and color, PF was transferred immediately to the laboratory for preparation. The PF was centrifuged at 400Ug for 20 min at 4³C and the supernatant was stored at 380³C until assay.
TNF-K activity in each PF was measured with a commercial enzyme-linked immunosorbent assay (ELISA) kit (Otsuka Assay Research Center, Tokushima, Japan) (Lot No. IA94). Protein concentration in each PF was measured by Bradford's method [10] .
In order to estimate the molecular size of the substances with inhibitory activity, a PF of an endometriosis patient (case 14, T.S., Re-AFS stage IV) was fractionated by ultra¢ltration with Microcon-10 (Grace Japan Co.), which is able to fractionate to a molecular mass of 10 R Da. Each ¢ltrated PF was stored at 380³C until assay.
Preparation and activation of mouse peritoneal macrophages
Male C3H/HeJ mice (6^8 weeks old) were injected intraperitoneally with 3 ml of 3% thioglycollate as described previously [8] . Four days later, peritoneal exudated cells (PEC) were collected and washed with phosphate-bu¡ered saline (PBS) (pH 7.3^7.65). These peritoneal cells were rinsed twice with Roswell Park Memorial Institute (RPMI 1640) medium containing 5% fetal calf serum (FCS) and adjusted to 1.0U10 T cells ml 3I . 100 Wl of the cell suspension was seeded into each well of a 96-well £at-bottomed microtiter plate. Then, peritoneal cells were incubated for 2 h in a 5% CO P incubator at 37³C.
After incubation, non-adherent cells were discarded. These monolayers, containing more than 90% MP as con¢rmed by methods described previously [8] , were preincubated with PF for 1 h. Then, these MP were incubated in the presence of 100 Wg ml 3I of a preparation of heat-killed Enterococcus faecalis (FK-23), which is a bacterial TNF inducer [11] , for an additional 3 h. As controls for inhibitory e¡ects, peritoneal MP were incubated with or without corticosterone (10 3T M). Corticosterone is a glucocorticoid with strong inhibitory e¡ects on the TNF production of MP as previously described [7] . After incubation with FK-23, the medium of each well was collected. These supernatants, obtained by centrifugation, were stored in aliquots at 380³C until the L929 cytotoxicity assay was performed as described below. Activity of PF samples was shown by the TNF-producing ratio which was calculated as [TNF produced by FK-23-stimulated MP in the presence of PF/in the absence of PF]. We previously reported the accuracy of this method by masking exclusively with an anti-TNF polyclonal antibody [12] .
Preparation and activation of human peripheral monocytes
20 ml of peripheral blood was drawn from a healthy male donor (blood type AB, Rh positive). Peripheral mononuclear cells were separated by Ficoll-Hypaque density gradient centrifugation. Mononuclear cells (2U10 S cells well 3I ) were cultured in RPMI 1640 medium containing 5% FCS in 96-well microtiter plates for 2 h at 37³C in 5% CO P . The non-adherent cells were discarded. These monolayers that were rich in monocytes were incubated with the PF for 1 h and then incubated with FK-23 for an additional 17 h. After incubation, the supernatant from each well was collected and immediately centrifuged. These preparations were stored in aliquots at 380³C until the L929 cytotoxicity assay.
L929 cytotoxicity assay
In vitro cytotoxicity against L929 cells was assayed by the methods of Ru¡ and Gi¡ord as described in detail elsewhere [13] . Brie£y, cultures of 8U10 S cells in 100 Wl of Eagle's minimum essential medium (EMEM) with 5% calf serum (CS) were established in 96-well £at-bottomed microtiter plates and in a 5% CO P incubator at 37³C for 3 h. 50 Wl of the sample and a ¢nal concentration of 1 Wg ml 3I actinomycin D were added to each well and incubated for 18 h in a 5% CO P incubator. After incubation, these L929 cells were stained with crystal violet and examined under an optical microscope. The absorbance at 540 nm was measured photometrically and the survival ratio was calculated as previously described [14] .
Statistical analysis
Statistical evaluation of the data was done with Student's t-test for di¡erences among groups or AN-OVA (Kruskal-Wallis for nonparametric evaluation) for correlation.
Results
Protein concentration and TNF-K activity in PF
The concentration of protein in PF obtained from 13 patients with endometriosis was determined. The mean protein concentration of PF was 44.2 mg ml 3I , ranging from 37.7 to 49.4 mg ml 3I (Fig. 1) . There was no signi¢cant correlation between protein concentration and Re-AFS classi¢cation (ANOVA, P=0.0530). As shown by the solid bars in Fig. 1 , signi¢cant levels of TNF-K ( s 25 pg ml 3I ) were detected in six cases of 13 (46%), ranging from 56.0 to 1200.0 pg ml 3I . No correlation was observed between TNF-K concentration and Re-AFS classi¢ca-tion.
E¡ect of PF on TNF-producing activity of macrophages (C3H/HeJ mouse peritoneal MP and human peripheral monocytes)
Fig . 2 shows the change of TNF-producing activity by serial dilution of PF from an endometriosis patient (case 14, T.S., Re-AFS classi¢cation stage IV). These dose-response curves reveal a suppressive e¡ect on TNF-producing activity in relation to the concentration of PF in a dose-dependent manner. Fig. 3 shows that TNF-producing activity in PFs of endometriosis patients (14/15 cases) was signi¢- cantly lower than that of the PF of the non-endometriosis patient. Moreover, in nine (of the 14) cases the TNF-producing activities induced by FK-23 were signi¢cantly lower than in corticosterone-treated specimens (Fig. 3) . However, there was no signi¢cant correlation between the inhibitory activity of PF and Re-AFS classi¢cation (Fig. 4) .
As regards molecular size, the higher molecular fraction (v10 R Da) of PF was signi¢cantly more suppressive than the lower molecular fraction ( 6 10 R Da) (Fig. 5) .
The inhibitory e¡ect of PF on human peripheral monocytes was also investigated. Compared with mouse peritoneal MP, TNF-producing activity from human monocytes which were incubated with FK-23 followed by PF samples was almost identical, since a signi¢cant correlation was observed between the values showing the TNF-producing activities obtained from two systems using human monocytes and murine macrophages (Fig. 6 ).
Discussion
Our results show that PF from endometriosis patients markedly suppressed the activation of mouse peritoneal MP stimulated by FK-23. In nine of the 15 samples of PF with endometriosis (60%), a strong suppressive e¡ect on the TNF-producing activity, induced by FK-23, was observed, comparable with that of corticosterone treatment. Abe et al. reported that very low, but physiological concentrations of corticosterone inhibit the cytotoxic activity of TNF against the L929 ¢broblast cell line [14] . Glucocorticoids are known to inhibit in£ammatory reactions through induction of de novo synthesis of lipocortin, a phospholipase A P inhibitor [15, 16] . We con¢rmed also that the inhibitory activity of PF was e¡ective on the TNF production in human monocytes. Therefore, we could assume that PF suppresses TNF production in peritoneal MP in patients with endometriosis.
MP are the cell type found in the greatest quantity in PF in endometriosis. The regulatory mechanisms . The relation of the inhibitory activity to various pathological parameters of endometriosis, such as Re-AFS classi¢cation, was tested. PF of patients in stage II or III seemed to be more suppressive on TNF production (Fig. 4) , but the di¡erence was not statistically signi¢cant. Protein concentration, volume and TNF concentration of PF did not seem to be correlated with its inhibitory activity. These relationships should be discussed after more detailed studies with a larger number of patients.
Thus, PF, which contains suppressive properties for the activation of peritoneal macrophages, might allow the implantation of free endometrial cells or the metaplastic phenomena stimulated by retrograde menstruation in endometriosis.
Oosterlynck et al. demonstrated that lymphocytes preincubated with the PF of women with severe endometriosis had a decreased cytotoxicity toward K562 target cells compared to lymphocytes preincubated with PF of women without endometriosis. So they suggested the presence of a suppressive factor in PF [17] .
Ultra¢ltration experiments with PF suggested that the molecular size of the inhibitory factors is larger than 1U10 R Da (Fig. 5) . Therefore, candidates for the inhibitory factor seemed to be high molecular mass substances rather than prostaglandins and or steroid hormones, such as estrogen (E P ), progesterone (P) and cortisol. The maintenance of extrauterine ectopic endometrial tissue appears to be under hormonal control with a requirement for E P and P [18, 19] . The concentrations of E P and P in the PF are the same in patients with or without endometriosis [20] .
Peritoneal £uid has been shown to have a toxic e¡ect on ovum pick-up, sperm mobility/survival, sperm-oocyte interaction and embryo development. Suginami et al. demonstrated an ovum capture inhibitor for the oviduct ¢mbriae present in endometriosis PF [21] . Clinically, it is well known that conception often occurs after diagnostic laparoscopy for Fig. 6 . The inhibitory e¡ects of PF on the TNF-producing activity of human peripheral monocytes and murine macrophages. Open and closed columns represent the TNF production of human monocytes or murine macrophages, respectively. The correlation coe¤cient between the TNF obtained from the two types of cells was calculated to be 0.91, P 6 0.05 by ANOVA. Fig. 5 . Inhibitory activity of the high molecular fraction of PF on TNF production of macrophages. PF from an endometriosis patient (case 14, T.S., Re-AFS stage IV) was fractionated by ultra¢ltration. High or low molecular fractions correspond to the fractions which were retained or ¢ltrated through the ultra¢lters (cut size MW: 10 R Da), respectively. Each fraction was added to culture medium for macrophages at a concentration equivalent to 5% of original PF. Statistically signi¢cant di¡erence from control by Student's t-test, *P 6 0.01. unexplained infertility and minimal endometriosis [22] . We can speculate that laparoscopic techniques, such as irrigation with copious £uids and suction removal of PF, might reduce the inhibitory factors from the PF in patients with endometriosis and minimize the abnormal immunologic milieu in the pelvic cavity. It is very important for the treatment of endometriosis to reestablish a normal immunologic homeostasis in the pelvic cavity. Further investigations are necessary for the evaluation of PF in order to better understand the pathophysiology of endometriosis.
